Marshall Wace, LLP Sanofi Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$45.46 - $50.51 $401,048 - $445,599	-8,822 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$45.3 - $51.62 $399,636 - $455,391	8,822 New	8,822 $429,000
Q3 2020 Nov 16, 2020	SELL	$49.47 - $53.77 $1.37 Million - $1.48 Million	-27,609 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$42.91 - $52.5 $1.18 Million - $1.45 Million	27,609 New	27,609 $1.41 Million
Q1 2020 May 15, 2020	SELL	$38.02 - $51.66 $14.8 Million - $20.2 Million	-390,118 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$44.25 - $50.86 $10.5 Million - $12.1 Million	238,189 Added 156.78%	390,118 $19.6 Million
Q3 2019 Nov 14, 2019	BUY	$40.34 - $46.64 $6.13 Million - $7.09 Million	151,929 New	151,929 $7.04 Million
Q3 2018 Nov 14, 2018	SELL	$40.0 - $44.84 $1.68 Million - $1.89 Million	-42,107 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $1.58 Million - $1.74 Million	42,107 New	42,107 $1.69 Million

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.